用于诊断患有癌症的患者进行长期静脉治疗方案的血管通路装置。
Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer.
机构信息
School of Nursing and Midwifery, University of Galway, Galway, Ireland.
Oncology Department, Portiuncula University Hospital, Galway, Ireland.
出版信息
Cochrane Database Syst Rev. 2024 Aug 30;8(8):CD015667. doi: 10.1002/14651858.CD015667.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the relative effectiveness and vascular access device (VAD)-related complications of VADs in people requiring prolonged systemic anti-cancer treatment.
摘要
这是一篇 Cochrane 综述（干预措施）的方案。其目的如下：评估在需要长期全身性抗癌治疗的人群中，不同血管通路装置（VAD）的相对有效性和与 VAD 相关的并发症。
相似文献
1
Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer.用于诊断患有癌症的患者进行长期静脉治疗方案的血管通路装置。
Cochrane Database Syst Rev. 2024 Aug 30;8(8):CD015667. doi: 10.1002/14651858.CD015667.
2
Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review.癌症患者全身抗癌治疗用血管通路装置类型：范围综述。
Crit Rev Oncol Hematol. 2024 Apr;196:104277. doi: 10.1016/j.critrevonc.2024.104277. Epub 2024 Mar 14.
3
Vascular access specialist teams for device insertion and prevention of failure.负责设备植入和预防故障的血管通路专家团队。
Cochrane Database Syst Rev. 2018 Mar 20;3(3):CD011429. doi: 10.1002/14651858.CD011429.pub2.
4
[Terminology concerning intravenous ports].[关于静脉输液港的术语]
Wiad Lek. 2015;68(1):111-4.
5
Options for venous access in ambulatory care: issues in selection and management.门诊护理中静脉通路的选择：选择与管理中的问题
J Infus Chemother. 1996 Fall;6(4):186-94.
6
Vascular access device type for systemic anti-cancer therapies: a scoping review protocol.血管通路装置类型用于全身抗癌治疗：范围综述方案。
Br J Nurs. 2023 Apr 6;32(7):S18-S22. doi: 10.12968/bjon.2023.32.7.S18.
7
PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.PICC-PORT在接受化疗的乳腺癌患者中的完全植入式血管通路装置
J Vasc Access. 2020 Jul;21(4):460-466. doi: 10.1177/1129729819884482. Epub 2019 Nov 1.
8
"I have such a hard time hitting myself, I thought it'd be easier": perspectives of hospitalized patients on injecting drugs into vascular access devices.“我很难自己给自己打针，我以为会更容易些”：住院患者对将药物注入血管通路装置的看法。
Harm Reduct J. 2022 May 26;19(1):54. doi: 10.1186/s12954-022-00637-1.
9
Devices for administering cancer drugs.癌症药物给药装置。
AAOHN J. 1987 Apr;35(4):172-4.
10
Closed system drug transfer devices for chemotherapy.用于化疗的密闭式药物转移装置
Nursing. 2016 Jan;46(1):67-8. doi: 10.1097/01.NURSE.0000475498.92643.b2.
本文引用的文献
1
Infusion Therapy Standards of Practice, 9th Edition.《输液治疗实践标准》第9版
J Infus Nurs. 2024;47(1S Suppl 1):S1-S285. doi: 10.1097/NAN.0000000000000532.
2
Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period.探讨治疗期结束后完全植入式静脉通路装置（TIVAD）相关血栓性闭塞的危险因素。
Sci Rep. 2023 Jul 4;13(1):10767. doi: 10.1038/s41598-023-37902-7.
3
Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study.接受全身抗癌治疗的患者中，外周置入中心静脉导管与植入式港的并发症发生率：一项回顾性队列研究。
Int J Cancer. 2023 Oct 1;153(7):1397-1405. doi: 10.1002/ijc.34612. Epub 2023 May 30.
4
Developing Criteria for Health Economic Quality Evaluation Tool.制定卫生经济质量评价工具标准。
Value Health. 2023 Aug;26(8):1225-1234. doi: 10.1016/j.jval.2023.04.004. Epub 2023 Apr 15.
5
Vascular access device type for systemic anti-cancer therapies: a scoping review protocol.血管通路装置类型用于全身抗癌治疗：范围综述方案。
Br J Nurs. 2023 Apr 6;32(7):S18-S22. doi: 10.12968/bjon.2023.32.7.S18.
6
Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline.非细胞毒性外渗损伤的管理：关于药物、治疗策略以及血管加压药和高渗盐水外周给药的重点更新
Pharmacotherapy. 2023 Apr;43(4):321-337. doi: 10.1002/phar.2794. Epub 2023 Apr 1.
7
Clinical study of complications of a peripherally inserted central catheter in cancer patients.外周置入中心静脉导管在癌症患者中的并发症的临床研究。
Nurs Open. 2023 Jul;10(7):4480-4489. doi: 10.1002/nop2.1690. Epub 2023 Feb 28.
8
Incidence, time to occurrence and predictors of peripheral intravenous cannula-related complications among neonates and infants in Northwest Ethiopia: an institutional-based prospective study.埃塞俄比亚西北部新生儿和婴儿外周静脉留置针相关并发症的发生率、发生时间及预测因素：一项基于机构的前瞻性研究
BMC Nurs. 2023 Jan 11;22(1):11. doi: 10.1186/s12912-022-01164-x.
9
Ultrasound guidance versus landmark method for peripheral venous cannulation in adults.超声引导与体表标志法在成人外周静脉置管中的比较。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD013434. doi: 10.1002/14651858.CD013434.pub2.
10
Usefulness of Midline Catheters versus Peripheral Venous Catheters in an Inpatient Unit: A Pilot Randomized Clinical Trial.住院病房中中线导管与外周静脉导管的效用：一项试点随机临床试验
Nurs Rep. 2022 Oct 31;12(4):814-823. doi: 10.3390/nursrep12040079.
Zotero 插件